Cancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but ...
For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are encouraging. But for a subset, remission is not the end of the story. Roughly 30% ...
Research reveals how dormant breast cancer cells survive in bone marrow and evade therapy for years CHINA, June 4, 2026 ...
A new research paper was recently published in Volume 17 of Genes & Cancer, titled "Active Beta-Catenin (ABC) promotes an ...
Growing momentum for RAS inhibition at ASCO highlights Namodenoson’s RAS pathway inhibition and encouraging data in pancreatic cancerRamat Gan, ...
An AI-assisted drug discovery platform using transfer learning has identified a promising gp130 inhibitor for colorectal ...
Targeting the WNT signaling pathway represents a promising strategy for cancer therapy. The field has evolved to include numerous inhibitors currently under preclinical and clinical investigation.
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
Breast cancer has been the most commonly diagnosed cancer among women worldwide for years running, but GLP-1s may help. The ...